Efficacy of mildly processed natural eggshell membrane in the alleviation of joint pain associated with osteoarthritis

Efficacy of mildly processed natural eggshell membrane in the alleviation of joint pain associated with osteoarthritis - Efficacy of eggshell membrane

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46782

Enrollment

150

Registered

2018-04-24

Start date

2018-09-08

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arthritis osteoarthritis

Interventions

For a period of 12 weeks one group receives a daily capsule containing 300 mg of eggshell membrane, and the other group daily receives a placebo capsule.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age between 40-75 NRS pain of 3 or more Diagnosed with osteoarthritis of the knee (confirmed by Health Care Professional)

Exclusion criteria

Exclusion criteria: Daily use of NSAIDs Use of opiates Use of supplements aimed to target specifically osteoarthritis and/or rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame
Main study parameter is observed change in self-reported pain on a Numeric Rating Scale (NRS pain) after 6 weeks as a result of intervention both for product and placebo.	—

Secondary

Measure	Time frame
Secondary, pain after 12 weeks (NRS pain), and other self reported disease related outcomes after 6 and 12 weeks will be assessed through Knee injury and Osteoarthritis Outcome Scores (KOOS).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)